SEOUL, South Korea, April 22, 2024 /PRNewswire/ OSR Holdings, a global healthcare holding company, announced that it has signed a memorandum of understanding with SillaJen, a Kosdaq-listed.
Press Releases - Investing com investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.
The two main drivers driving up the value of the oncolytic virus immunotherapy market are the rising incidence of cancer and the increase in healthcare.
The two main drivers driving up the value of the oncolytic virus immunotherapy market are the rising incidence of cancer and the increase in healthcare expenditures.Wilmington, Delaware, United States, Feb. 21, 2024 (GLOBE NEWSWIRE) Transparency Market Research Inc. - The global oncolytic virus immunotherapy market was projected to attain US$ 110.2 million in 2022. It is anticipated to garner a 21.1% CAGR from 2023 to 2031 and by 2032, the market is likely to attain US$ 572.2 million by 2031.
Oncolytic Virus Cancer Therapy Market Set to Reach US$ 250 Million by 2033| Future Market Insights,Inc fmiblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fmiblog.com Daily Mail and Mail on Sunday newspapers.